Bausch Health Co. Inc. (BHC) Tops Q4 EPS by 12c; offers guidance

Bausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of $1.15, $0.12 better than the analyst estimate of $1.03. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.29 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2024 revenue of $9.3-9.55 billion, versus the consensus of $8.971 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• BofA lists top 5 themes driving next $1tn in incremental semi sales